President Trump has returned from his holiday in Florida and is officially back to work. Congress is back in session tomorrow and there is a lot to get done. Lawmakers will be voting on many items like immigration, disaster relief, and more. Will the two sides of the aisle be able to work together, or will divisions hinder Washington?
Colby Hall is the managing editor at Mediate. He joins Cheddar to explain what agenda items will immediately be addressed. Washington is looking to tackle the issue of immigration with the Dreamers Act. There is also a disaster relief bill on the table that could be record-breaking. And of course, passing an official budget deal.
Hall notes the importance passing these legislative measures could have on the midterm election. We are 308 days away from the midterm elections, and it will be a race to determine whether Republicans hold onto their majority in Congress.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
